Committed to sharing our science

Committed to sharing our science

335 results available

Aficamten in Patients with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (REDWOOD-HCM Cohort 4)

Poster, ACC.23
Marsri A, et al
New Orleans, LA
March 4, 2023
Preclinical Characterization of CK-4021586, a New Class of Cardiac Myosin Inhibitors for the Treatment of Hypertrophic Cardiomyopathy

Poster, Biophysical Society Annual Meeting
Sarkar SS, et al
San Diego, CA
February 18, 2023
Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HF

Journal of the American College of Cardiology: Heart Failure
Lanfear DE, et al
February 1, 2023
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: Insights from the GALACTIC-HF trial

European Journal of Heart Failure
Docherty KF, et al
January 4, 2023
Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy

Scientific Reports
Sharpe AN, et al
January 2, 2023